SCHEMBL2901922

SCHEMBL2901922

O=S(=O)(Nc1cccc2nc(Nc3cccc(C4CC4)c3)ccc12)c1cc(F)cc(F)c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 7/20 0.40
TP53 P04637 3/20 0.40
CLK1 P49759 1/20 0.35
RECQL P46063 1/20 0.34
MEN1 O00255 3/20 0.34
ALDH1A1 P00352 3/20 0.34
KMT2A Q03164 3/20 0.34
SLC40A1 Q9NP59 1/20 0.34
ABCG2 Q9UNQ0 1/20 0.34
MAP2K7 O14733 1/20 0.34
MAP2K4 P45985 1/20 0.34
GAA P10253 1/20 0.34
MAPK1 P28482 1/20 0.34
APOBEC3G Q9HC16 1/20 0.34
ACLY P53396 1/20 0.34
RAF1 P04049 1/20 0.34
BRAF P15056 1/20 0.34
POLB P06746 1/20 0.33
CSNK2A1 P68400 1/20 0.33
SCN9A Q15858 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2906872 0.85 SLC10A2 (0.45) MAPTTP53RECQLMEN1ALDH1A1
SCHEMBL2910554 0.83 CLK1 (0.52) MAPTTP53CLK1MEN1KMT2A
SCHEMBL2904870 0.82 MEN1 (0.49) MAPTTP53MEN1ALDH1A1KMT2A
SCHEMBL2904980 0.82 EGFR (0.44) MAPTTP53CLK1MEN1KMT2A
SCHEMBL2907742 0.79 RECQL (0.53) MAPTCLK1RECQLMEN1ALDH1A1
SCHEMBL2905319 0.77 LMNA (0.44) MAPTCLK1MEN1ALDH1A1KMT2A
SCHEMBL2906708 0.77 IDO1 (0.42) MAPTCLK1RECQLALDH1A1KMT2A
SCHEMBL1615546 0.76 SCN1A (0.41) MAPTRECQLMEN1ALDH1A1KMT2A
SCHEMBL2926162 0.76 SCN1A (0.41) MAPTRECQLMEN1ALDH1A1KMT2A
SCHEMBL2902345 0.76 EPHB4 (0.47) MAPTCLK1RECQLMEN1ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 10 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7825253-B2 2-aminoquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2010-11-02 US claimed
EP-2076495-B1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES HOFFMANN LA ROCHE (CH) 2010-08-18 EP claimed
EP-2076495-A1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES F.HOFFMANN-LA ROCHE AG (CH) 2009-07-08 EP claimed
WO-2008037626-A1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES F. HOFFMANN-LA ROCHE AG (CH) 2008-04-03 WO claimed
US-20080081907-A1 2-AMINOQUINOLINE DERIVATIVES HOFFMANN-LA ROCHE INC. 2008-04-03 US claimed
US-7825253-B2 2-aminoquinoline derivatives HOFFMANN-LA ROCHE INC. (US) 2010-11-02 US disclosed
EP-2076495-B1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES HOFFMANN LA ROCHE (CH) 2010-08-18 EP disclosed
EP-2076495-A1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES F.HOFFMANN-LA ROCHE AG (CH) 2009-07-08 EP disclosed
WO-2008037626-A1 QUINOLINE DERIVATIVES WITH 5-HT-BINDING PROPERTIES F. HOFFMANN-LA ROCHE AG (CH) 2008-04-03 WO disclosed
US-20080081907-A1 2-AMINOQUINOLINE DERIVATIVES HOFFMANN-LA ROCHE INC. 2008-04-03 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080081907-A1 2-AMINOQUINOLINE DERIVATIVES AR, ADRA2C, RCC2 MAPT 1716/4885TP53 2398/4885CLK1 3082/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.